Catalent Inc (NYSE:CTLT)

102.70
BATS BZX Real-Time Price
As of 11:53am ET
 +2.22 / +2.21%
Today’s Change
67.97
Today|||52-Week Range
127.68
-1.32%
Year-to-Date
Minerva (NERV) Soars on Promising Schizophrenia Study Data
May 12 / Zacks.com - Paid Partner Content
Catalent Inc (CTLT) Q3 2021 Earnings Call Transcript
May 04 / MotleyFool.com - Paid Partner Content
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?
May 07 / Zacks.com - Paid Partner Content
Catalent (CTLT) Tops Q3 Earnings and Revenue Estimates
May 04 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close100.48
Today’s open101.00
Day’s range100.45 - 102.74
Volume210,595
Average volume (3 months)1,071,637
Market cap$18.3B
Data as of 11:53am ET, 05/14/2021

Growth & Valuation

Earnings growth (last year)+26.20%
Earnings growth (this year)+35.22%
Earnings growth (next 5 years)+20.92%
Revenue growth (last year)+22.89%
P/E ratio34.1
Price/Sales3.61
Price/Book6.04

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+0.25+0.30%
VTRSViatris Inc-0.11-0.69%
HZNPHorizon Therapeutics...+3.67+4.18%
ALNYAlnylam Pharmaceutic...+2.96+2.22%
Data as of 11:52am ET, 05/14/2021

Financials

Next reporting dateAugust 30, 2021
EPS forecast (this quarter)$1.10
Annual revenue (last year)$3.1B
Annual profit (last year)$173.0M
Net profit margin5.59%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Somerset, New Jersey

Forecasts